Dr Meryl A Severson Iii, MD | |
105 W 8th Ave, Suite 200, Spokane, WA 99204-2302 | |
(509) 624-9112 | |
(509) 624-1087 |
Full Name | Dr Meryl A Severson Iii |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 105 W 8th Ave, Spokane, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427265248 | NPI | - | NPPES |
70337 | Other | IA | WELLMARK BCBS |
Entity Name | Private Diagnostic Clinic Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States Food and Drug Administration voted to recommend approval of Takeda's vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Yuntao Wu, Professor, Molecular and Microbiology, and Ramin Hakami, Associate Professor, School of Systems Biology, are conducting studies of COVID-19 therapies.
The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 1 days ago
Entity Name | Duke Health Integrated Practice Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States Food and Drug Administration voted to recommend approval of Takeda's vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Yuntao Wu, Professor, Molecular and Microbiology, and Ramin Hakami, Associate Professor, School of Systems Biology, are conducting studies of COVID-19 therapies.
The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Meryl A Severson Iii, MD Po Box 421, Liberty Lake, WA 99019-0421 Ph: (866) 747-2455 | Dr Meryl A Severson Iii, MD 105 W 8th Ave, Suite 200, Spokane, WA 99204-2302 Ph: (509) 624-9112 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States Food and Drug Administration voted to recommend approval of Takeda's vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Yuntao Wu, Professor, Molecular and Microbiology, and Ramin Hakami, Associate Professor, School of Systems Biology, are conducting studies of COVID-19 therapies.
The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 1 days ago
Dr. Robert D Martz, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 105 W 8th Ave, Ste 200, Spokane, WA 99204 Phone: 509-624-9112 Fax: 509-624-1087 | |
Alexander R Mackay, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 910 W 5th Ave, Suite 102, Spokane, WA 99204 Phone: 509-228-1000 Fax: 509-252-9300 | |
Dr. Allan Christopher Heller, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 W 5th Ave, Suite #525, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 | |
Cynthia A Hahn, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 212 E Central Ave, Suite 360, Spokane, WA 99208 Phone: 509-489-6757 Fax: 509-489-0665 | |
Kathleen L Meyer, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 715 S Cowley St, Suite 210, Spokane, WA 99202 Phone: 509-624-5351 Fax: 509-455-9331 | |
Dr. Yiping Li, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 W 8th Ave Ste 200, Spokane, WA 99204 Phone: 509-624-9112 Fax: 509-227-7070 |